Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 5
2004 3
2005 6
2006 6
2007 11
2008 4
2009 11
2010 7
2011 10
2012 13
2013 17
2014 15
2015 8
2016 8
2017 13
2018 9
2019 8
2020 20
2021 31
2022 29
2023 17
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Results by year

Filters applied: . Clear all
Page 1
Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non-Small Cell Lung Cancer.
Khorrami M, Prasanna P, Gupta A, Patil P, Velu PD, Thawani R, Corredor G, Alilou M, Bera K, Fu P, Feldman M, Velcheti V, Madabhushi A. Khorrami M, et al. Among authors: fu p. Cancer Immunol Res. 2020 Jan;8(1):108-119. doi: 10.1158/2326-6066.CIR-19-0476. Epub 2019 Nov 12. Cancer Immunol Res. 2020. PMID: 31719058 Free PMC article.
Survival in elderly patients with breast cancer with and without autoimmune disease.
Dedousis D, Zhang AL, Vassiliou AN, Cao S, Yammani D, Kyasaram RK, Shanahan JP, Keinath MC, Hsu ML, Fu P, Dowlati A, Montero AJ. Dedousis D, et al. Among authors: fu p. Cancer Med. 2023 Jun;12(12):13086-13099. doi: 10.1002/cam4.5989. Epub 2023 Apr 26. Cancer Med. 2023. PMID: 37102221 Free PMC article.
Retinoblastoma Expression and Targeting by CDK4/6 Inhibitors in Small Cell Lung Cancer.
Wildey G, Shay AM, McColl KS, Yoon S, Shatat MA, Perwez A, Spainhower KB, Kresak AM, Lipka M, Yang M, Behtaj M, Fu P, Alahmadi A, Mneimneh W, Abbas A, Dowlati A. Wildey G, et al. Among authors: fu p. Mol Cancer Ther. 2023 Feb 1;22(2):264-273. doi: 10.1158/1535-7163.MCT-22-0365. Mol Cancer Ther. 2023. PMID: 36399634 Free PMC article.
Deep computational image analysis of immune cell niches reveals treatment-specific outcome associations in lung cancer.
Barrera C, Corredor G, Viswanathan VS, Ding R, Toro P, Fu P, Buzzy C, Lu C, Velu P, Zens P, Berezowska S, Belete M, Balli D, Chang H, Baxi V, Syrigos K, Rimm DL, Velcheti V, Schalper K, Romero E, Madabhushi A. Barrera C, et al. Among authors: fu p. NPJ Precis Oncol. 2023 Jun 1;7(1):52. doi: 10.1038/s41698-023-00403-x. NPJ Precis Oncol. 2023. PMID: 37264091 Free PMC article.
Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer.
Wilkerson AD, Parthasarathy PB, Stabellini N, Mitchell C, Pavicic PG Jr, Fu P, Rupani A, Husic H, Rayman PA, Swaidani S, Abraham J, Budd GT, Moore H, Al-Hilli Z, Ko JS, Baar J, Chan TA, Alban T, Diaz-Montero CM, Montero AJ. Wilkerson AD, et al. Among authors: fu p. Clin Cancer Res. 2024 Jan 5;30(1):82-93. doi: 10.1158/1078-0432.CCR-23-1349. Clin Cancer Res. 2024. PMID: 37882661 Free PMC article. Clinical Trial.
230 results